ROLE OF ENTEROSORPTION IN THE TREATMENT OF LIVER DISEASES, 2008

I.G. Paliy, MD, Professor, Department of outpatient therapy and family medicine, National Pirogov Memorial Medical University, Vinnytsya Thus, the high efficiency of enterosorbent Enterosgel, its selective sorption action, simplicity and safety, and the possibility of a combination with other medications allow the medical officer to optimize the therapeutic tactics in various diseases of the liver, [...]
Read More

EFFECTIVENESS OF ENTEROSORPTION METHOD IN GASTROENTEROLOGY, 2008

 I. G. Paliy, I. G. Reznichenko The high effectiveness of intestinal adsorbent (enterosorbent) Enterosgel as a detoxifying agent in infectious and inflammatory diseases is associated with its ability to adsorb MWM and pathogenic micro-organisms, thereby positively influencing the cellular and humoral immunity. Enterosgel contributes to enhancing the functional activity of neutrophilic granulocytes to the level [...]
Read More

ENTEROSOBTION IN PAEDIATRIC PRACTICE: SELECTION OF OPTIMAL SORBENT, 2010

N.V. Nagornaya, M.P. Limarenko, M. Gorky National Medical University of Donetsk In such a manner, Enterosgel® improves the efficiency of treatment of allergic diseases, due to the following mechanisms: 1) normalizes the function of the digestive tract and immune system; 2) restores the normal composition of intestinal microflora; 3) reduces antigenic load on the digestive [...]
Read More

CLINICAL EFFECTIVENESS OF ENTEROSORPTION IN REDUCTION OF ENDOGENOUS INTOXICATION SYNDROME IN PATIENTS WITH NONSPECIFIC ULCERATIVE COLITIS, 2009

O.Osadchaya, A. Boyarskaya In patients with active UC there is a significant decompensation of toxin-binding capacity of albumin. Meantime, involvement of globulins occurs in processes of toxins elimination, which alter their properties and can cause development of infectious complications in patients with UC. Use of enterosorbent Enterosgel in combination treatment of patients with UC helps [...]
Read More

EXPERIMENTAL CLINICAL STUDY OF ENTEROSGEL (METHYLSILICIC ACID HYDROGEL) APPLICATION IN ONCOLOGY PATIENTS DURING THE COURSES OF GAMMA TELETHERAPY AND CHEMORADIOTHERAPY, 2001

Yu.N. Shevchenko, Yu.A. Serezhko Conclusions 1. During EBRT, all patients have experienced an increase of endogenous intoxication, which can be an indicator of the level of medium-weight molecules. However, in patients treated with Enterosgel, medium-weight molecules level was lower than in the control group and did not rise above 0.300 relative units of extinction. 2. [...]
Read More